Who
Kim Kelderman
Director
Company insider
Files Form 4 as: Director, Conmed; Chief Executive Officer, Bio-Techne.
In numbers
- Trades disclosed
- 144
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $2.8M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 May 2018
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | CNMD ConmedMedical Devices | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CNMD Conmedoption or derivative · Medical Devices | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | CNMD ConmedMedical Devices | SEC FORM 4 Code M | —500 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —57,590 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —93,582 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —57,590 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —93,582 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code M | —21,470 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,785 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code F | $783K10,821 at $72.40 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —554 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —554 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code D | —8,319 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code D | —22,389 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —588 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code D | —8,835 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code D | —24,324 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —8,543 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,785 at $0.00 | filing |
News
Bio-Techne opens GMP small molecule facility in Bristol, UKTECH · pharmaceutical-business-review.com · 9 Oct 2026
0 headlines in the last 90 days name Kim Kelderman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.